Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.53p
   
  • Change Today:
      0.000p
  • 52 Week High: 2.40
  • 52 Week Low: 0.42
  • Currency: UK Pounds
  • Shares Issued: 374.35m
  • Volume: 160,078
  • Market Cap: £1.97m
  • RiskGrade: 435
  • Beta: 0.12

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
96.66% above the market average96.66% above the market average96.66% above the market average96.66% above the market average96.66% above the market average
93.10% above the sector average93.10% above the sector average93.10% above the sector average93.10% above the sector average93.10% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
72.06% above the market average72.06% above the market average72.06% above the market average72.06% above the market average72.06% above the market average
73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average73.91% above the sector average
Price Book Ratio
74.74% above the market average74.74% above the market average74.74% above the market average74.74% above the market average74.74% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
91.11% below the market average91.11% below the market average91.11% below the market average91.11% below the market average91.11% below the market average
86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average86.67% below the sector average
Price Chg 3m
10.55% below the market average10.55% below the market average10.55% below the market average10.55% below the market average10.55% below the market average
2.22% below the sector average2.22% below the sector average2.22% below the sector average2.22% below the sector average2.22% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
83.44% below the market average83.44% below the market average83.44% below the market average83.44% below the market average83.44% below the market average
95.24% below the sector average95.24% below the sector average95.24% below the sector average95.24% below the sector average95.24% below the sector average
Momentum 20
9.39% below the market average9.39% below the market average9.39% below the market average9.39% below the market average9.39% below the market average
23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
97.61% below the market average97.61% below the market average97.61% below the market average97.61% below the market average97.61% below the market average
86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
62.18% below the market average62.18% below the market average62.18% below the market average62.18% below the market average62.18% below the market average
39.53% below the sector average39.53% below the sector average39.53% below the sector average39.53% below the sector average39.53% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
95.4% below the market average95.4% below the market average95.4% below the market average95.4% below the market average95.4% below the market average
86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average
Operating Profit Loss
56.53% below the market average56.53% below the market average56.53% below the market average56.53% below the market average56.53% below the market average
20.93% above the sector average20.93% above the sector average20.93% above the sector average20.93% above the sector average20.93% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
72.76% below the market average72.76% below the market average72.76% below the market average72.76% below the market average72.76% below the market average
45% below the sector average45% below the sector average45% below the sector average45% below the sector average45% below the sector average
Cash
48.2% below the market average48.2% below the market average48.2% below the market average48.2% below the market average48.2% below the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.53p
Change Today 0.000p
% Change 0.00 %
52 Week High 2.40
52 Week Low 0.42
Volume 160,078
Shares Issued 374.35m
Market Cap £1.97m
Beta 0.12
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.85% above the market average41.85% above the market average41.85% above the market average41.85% above the market average41.85% above the market average
48.84% above the sector average48.84% above the sector average48.84% above the sector average48.84% above the sector average48.84% above the sector average
Price Trend
85.66% below the market average85.66% below the market average85.66% below the market average85.66% below the market average85.66% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Income Not Available
Growth
26.42% above the market average26.42% above the market average26.42% above the market average26.42% above the market average26.42% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Valirx Dividends

No dividends found

Trades for 18-Aug-2025

Time Volume / Share Price
14:22 225 @ 0.55p
13:39 90,909 @ 0.55p
13:06 63,019 @ 0.55p
10:43 436 @ 0.50p
08:34 5,489 @ 0.55p

Valirx Key Personnel

CFO Gerald Desler

Top of Page